Seres Therapeutics (MCRB) Institutional Ownership $0.81 +0.13 (+19.01%) (As of 11/20/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Institutional Ownership Changes (13F Filings) for Seres Therapeutics (NASDAQ:MCRB)CurrentInstitutional OwnershipPercentage59.34%Number ofInstitutional Buyers(last 12 months)17TotalInstitutional Inflows(last 12 months)$5.81MNumber ofInstitutional Sellers(last 12 months)5TotalInstitutional Outflows(last 12 months)$234.63K Get MCRB Insider Trade Alerts Want to know when executives and insiders are buying or selling Seres Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data MCRB Institutional Buying and Selling by Quarter Ad Behind the Markets📉 Warning: Market Crash Predicted - Secure Your SavingsThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Take these 4 steps to protect your retirement here >>> Seres Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/20/2024Virtu Financial LLC58,791$56K0.0%+44.8%0.034% 11/16/2024 Geode Capital Management LLC1,388,639$1.31M0.0%+22.5%0.816% 11/15/2024 State Street Corp383,248$363K0.0%+12.9%0.225% 11/15/2024 Point72 Asia Singapore Pte. Ltd.44,972$43K0.0%-64.8%0.026% 11/14/2024 Providence Wealth Advisors LLC98,500$93K0.1%+29.2%0.058% 11/13/2024 FMR LLC22,857,260$21.63M0.0%+0.6%13.430% Get the Latest News and Ratings for MCRB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Seres Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/12/2024 Charles Schwab Investment Management Inc.748,718$708K0.0%+42.4%0.440% 10/16/2024 Vontobel Holding Ltd.394,826$374K0.0%N/A0.261% 9/16/2024 Point72 DIFC Ltd87,754$64K0.0%N/A0.058% 9/16/2024 Point72 Asia Singapore Pte. Ltd.127,634$92K0.0%N/A0.084% 8/15/2024 Point72 Asia Singapore Pte. Ltd.127,634$92K0.0%N/A0.084% 8/14/2024 Point72 DIFC Ltd87,754$64K0.0%N/A0.058% 8/9/2024 Providence Wealth Advisors LLC76,250$58K0.0%+49.5%0.050% 8/1/2024 Rhumbline Advisers55,112$40K0.0%-61.0%0.036% 5/20/2024Virtu Financial LLC94,510$73K0.0%N/A0.062% 5/15/2024 Price T Rowe Associates Inc. MD298,111$232K0.0%-18.0%0.197% 5/10/2024 Vanguard Group Inc.6,734,821$5.21M0.0%+12.1%4.460% 5/1/2024 BNP Paribas Financial Markets46,549$36K0.0%-19.8%0.031% 5/1/2024 Mirae Asset Global Investments Co. Ltd.50,102$39K0.0%N/A0.033% 2/14/2024 Pennant Investors LP292,300$409K0.1%N/A0.226% 2/13/2024 Tower Research Capital LLC TRC38,091$53K0.0%+668.6%0.029% 2/1/2024 Handelsbanken Fonder AB1,100,000$1.54M0.0%+10.0%0.851% 1/24/2024 Clear Creek Financial Management LLC26,950$38K0.0%-47.6%0.021% 1/12/2024 SG Americas Securities LLC52,080$73K0.0%N/A0.040% 12/7/2023 Hudson Bay Capital Management LP1,999,800$4.76M0.0%+127.3%1.547% 11/22/2023 Graham Capital Management L.P.206,838$492K0.0%+731.3%0.160% 11/14/2023 Corton Capital Inc.23,245$55K0.0%-64.7%0.018% 11/14/2023 Profund Advisors LLC155,798$371K0.0%+11.9%0.121% 11/13/2023 Federated Hermes Inc.8,981,717$21.38M0.1%-21.2%6.949% 11/13/2023 Dark Forest Capital Management LP117,498$280K0.0%N/A0.091% 11/13/2023 Aigen Investment Management LP75,241$179K0.0%+577.1%0.058% 11/13/2023 FMR LLC19,230,692$45.77M0.0%+0.2%14.878% 11/13/2023 Rafferty Asset Management LLC936,382$2.23M0.0%+21.1%0.724% 11/7/2023 Quantbot Technologies LP50,400$120K0.0%N/A0.039% 11/7/2023 Barclays PLC461,209$1.10M0.0%+24.3%0.360% 10/30/2023 Arete Wealth Advisors LLC24,900$59K0.0%+99.2%0.019% 10/23/2023Commonwealth Equity Services LLC11,040$26K0.0%N/A0.009% 10/19/2023Simplicity Solutions LLC11,294$27K0.0%N/A0.009% 10/11/2023 Vontobel Holding Ltd.17,000$40K0.0%-52.6%0.013% 8/14/2023 Great Point Partners LLC938,067$4.49M0.9%N/A0.732% This company will win the AI race (Ad)Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse. You must read this new presentation from Porter Stansberry.8/14/2023 UniSuper Management Pty Ltd415,292$1.99M0.0%N/A0.324% 8/14/2023 Parallax Volatility Advisers L.P.134,901$646K0.0%N/A0.105% 8/14/2023 Graham Capital Management L.P.24,881$119K0.0%N/A0.019% 8/11/2023 Natixis99,000$474K0.0%N/A0.077% 8/11/2023 E Fund Management Co. Ltd.41,581$199K0.0%+206.1%0.032% 8/11/2023 ExodusPoint Capital Management LP594,895$2.85M0.0%N/A0.464% 8/10/2023 Profund Advisors LLC139,249$667K0.0%+210.4%0.109% 8/9/2023 BNP Paribas Arbitrage SNC154,663$741K0.0%+61.9%0.121% 8/7/2023 Principal Financial Group Inc.45,205$217K0.0%+21.5%0.035% 8/4/2023 American International Group Inc.46,820$224K0.0%+37.7%0.037% 8/3/2023 Jennison Associates LLC1,392,356$6.67M0.0%+109.5%1.089% 8/2/2023 Handelsbanken Fonder AB1,000,000$4.79M0.0%+25.0%0.782% 7/31/2023 LPL Financial LLC115,058$551K0.0%+20.3%0.090% 7/31/2023 Alpha DNA Investment Management LLC138,536$664K0.2%N/A0.108% 7/28/2023 Mach 1 Financial Group LLC94,961$455K0.1%N/A0.074% 7/26/2023 Janney Montgomery Scott LLC90,285$432K0.0%-11.7%0.071% 7/25/2023Raymond James & Associates10,052$48K0.0%N/A0.008% 7/24/2023 Vontobel Holding Ltd.35,865$172K0.0%+74.6%0.028% 7/21/2023 Creative Planning17,304$83K0.0%N/A0.014% 7/19/2023 Teacher Retirement System of Texas27,360$131K0.0%-10.9%0.021% 7/18/2023 Diversified Trust Co10,000$48K0.0%N/A0.008% 7/17/2023 Clear Creek Financial Management LLC54,200$260K0.0%N/A0.042% 7/14/2023 Aries Wealth Management18,000$86K0.0%+50.0%0.014% 7/13/2023 Cambridge Investment Research Advisors Inc.44,844$215K0.0%N/A0.035% 7/10/2023 AE Wealth Management LLC95,188$456K0.0%N/A0.074% 7/7/2023 Auour Investments LLC17,000$81K0.0%N/A0.013% 5/16/2023 Avoro Capital Advisors LLC1,295,000$7.34M0.1%N/A1.013% 5/15/2023 Atom Investors LP90,388$512K0.3%-5.4%0.071% 5/12/2023 Profund Advisors LLC44,859$254K0.0%N/A0.035% 5/11/2023 PFG Investments LLC20,500$116K0.0%N/A0.016% 5/11/2023 FMR LLC18,911,458$107.23M0.0%+1.2%14.794% 5/11/2023 Knott David M Jr315,000$1.79M0.7%+57.4%0.246% 5/11/2023 E Fund Management Co. Ltd.13,585$77K0.0%-18.5%0.011% 5/10/2023 Oppenheimer & Co. Inc.37,111$210K0.0%N/A0.029% 5/10/2023 Simplify Asset Management Inc.550,626$3.12M0.4%N/A0.431% 5/8/2023 Federated Hermes Inc.15,277,356$86.62M0.2%-15.5%11.951% 5/8/2023 Zurcher Kantonalbank Zurich Cantonalbank24,010$136K0.0%+39.0%0.019% 5/4/2023 Barclays PLC110,060$624K0.0%-37.7%0.086% 5/4/2023 Mirae Asset Global Investments Co. Ltd.62,240$353K0.0%+16.9%0.049% 5/2/2023 Venturi Wealth Management LLC20,000$113K0.0%N/A0.016% 4/28/2023 SG Americas Securities LLC43,684$248K0.0%+206.6%0.034% 4/28/2023 Janney Montgomery Scott LLC102,281$580K0.0%+5.5%0.080% 4/28/2023 Handelsbanken Fonder AB800,000$4.54M0.0%N/A0.626% 4/26/2023 Jennison Associates LLC664,734$3.77M0.0%-0.6%0.527% 4/20/2023 Hennion & Walsh Asset Management Inc.61,090$346K0.0%-3.3%0.048% 4/18/2023 Macroview Investment Management LLC5,750$33K0.1%N/A0.005% 4/12/2023 Vontobel Holding Ltd.20,539$116K0.0%N/A0.016% 4/11/2023 Aries Wealth Management12,000$68K0.0%+20.0%0.010% 3/23/2023 MetLife Investment Management LLC31,931$179K0.0%-17.2%0.025% 2/15/2023 Eversept Partners LP2,200,999$12.33M1.1%+13.7%1.767% Financial Prophecy (Ad)The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.Including the name of the #1 company to buy.2/13/2023 Boulder Hill Capital Management LP20,200$113K0.1%N/A0.016% 2/13/2023 Knott David M Jr200,100$1.12M0.4%+81.9%0.161% 2/10/2023 Sit Investment Associates Inc.265,000$1.48M0.0%+33.2%0.213% 2/9/2023 Jennison Associates LLC668,441$3.74M0.0%N/A0.537% 2/9/2023 Principal Financial Group Inc.41,653$233K0.0%+99.5%0.033% 2/8/2023 Swiss National Bank239,700$1.34M0.0%+3.0%0.192% 2/7/2023 LPL Financial LLC92,901$520K0.0%-8.1%0.075% 2/6/2023 Los Angeles Capital Management LLC63,094$353K0.0%-21.8%0.051% 2/1/2023 Zurcher Kantonalbank Zurich Cantonalbank17,276$97K0.0%+61.9%0.014% 2/1/2023 Janney Montgomery Scott LLC96,954$543K0.0%+14.3%0.078% (Data available from 1/1/2016 forward) MCRB Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of MCRB shares? During the previous two years, 71 institutional investors and hedge funds held shares of Seres Therapeutics. The most heavily invested institutionals were FMR LLC ($21.63M), Federated Hermes Inc. ($21.38M), Eversept Partners LP ($12.33M), Avoro Capital Advisors LLC ($7.34M), Jennison Associates LLC ($6.67M), Vanguard Group Inc. ($5.21M), and Hudson Bay Capital Management LP ($4.76M).Learn more on MCRB's institutional investors. What percentage of Seres Therapeutics stock is owned by institutional investors? 59.34% of Seres Therapeutics stock is owned by institutional investors. Learn more on MCRB's institutional investor holdings. Which institutional investors have been buying Seres Therapeutics stock? Of the 62 institutional investors that purchased Seres Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Jennison Associates LLC ($1.40M), Avoro Capital Advisors LLC ($1.30M), Hudson Bay Capital Management LP ($1.12M), Handelsbanken Fonder AB ($1.10M), Great Point Partners LLC ($938.07K), Vanguard Group Inc. ($729.51K), and ExodusPoint Capital Management LP ($594.90K). How much institutional buying is happening at Seres Therapeutics? Institutional investors have bought a total of 13,016,833 shares in the last 24 months. This purchase volume represents approximately $50.37M in transactions. Which Seres Therapeutics major shareholders have been selling company stock? Of the 18 institutional investors that sold Seres Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Federated Hermes Inc. ($5.22M), Rhumbline Advisers ($86.34K), Point72 Asia Singapore Pte. Ltd. ($82.66K), Barclays PLC ($66.61K), Price T Rowe Associates Inc. MD ($65.54K), Corton Capital Inc. ($42.53K), and Clear Creek Financial Management LLC ($24.50K). How much institutional selling is happening at Seres Therapeutics? Institutional investors have sold a total of 5,681,963 shares in the last 24 months. This volume of shares sold represents approximately $22.76M in transactions. Related Companies NKTR Institutional Ownership FGEN Institutional Ownership MGTX Institutional Ownership XERS Institutional Ownership SIGA Institutional Ownership RNAC Institutional Ownership AURA Institutional Ownership AQST Institutional Ownership KRRO Institutional Ownership TSHA Institutional Ownership This page (NASDAQ:MCRB) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Seres Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Seres Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
